These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11896464)

  • 41. Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme.
    Feng M; Cabrera G; Deshane J; Scanlon KJ; Curiel DT
    Cancer Res; 1995 May; 55(10):2024-8. PubMed ID: 7743496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
    Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic expression of an anti-death receptor 5 single-chain fixed-variable region prevents tumor growth in mice.
    Shi J; Liu Y; Zheng Y; Guo Y; Zhang J; Cheung PT; Xu R; Zheng D
    Cancer Res; 2006 Dec; 66(24):11946-53. PubMed ID: 17178893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coxsackievirus adenovirus receptor expression predicts the efficiency of adenoviral gene transfer into non-small cell lung cancer xenografts.
    Qin M; Chen S; Yu T; Escuadro B; Sharma S; Batra RK
    Clin Cancer Res; 2003 Oct; 9(13):4992-9. PubMed ID: 14581374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostate-specific expression of the diphtheria toxin A chain (DT-A): studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer.
    Li Y; McCadden J; Ferrer F; Kruszewski M; Carducci M; Simons J; Rodriguez R
    Cancer Res; 2002 May; 62(9):2576-82. PubMed ID: 11980652
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
    Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
    Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial.
    Alvarez RD; Barnes MN; Gomez-Navarro J; Wang M; Strong TV; Arafat W; Arani RB; Johnson MR; Roberts BL; Siegal GP; Curiel DT
    Clin Cancer Res; 2000 Aug; 6(8):3081-7. PubMed ID: 10955787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo restoration of RhoB expression leads to ovarian tumor regression.
    Couderc B; Pradines A; Rafii A; Golzio M; Deviers A; Allal C; Berg D; Penary M; Teissie J; Favre G
    Cancer Gene Ther; 2008 Jul; 15(7):456-64. PubMed ID: 18340357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted gene delivery to mammalian cells by filamentous bacteriophage.
    Poul MA; Marks JD
    J Mol Biol; 1999 Apr; 288(2):203-11. PubMed ID: 10329137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological effects of anti-ErbB2 single chain antibodies selected for internalizing function.
    Neve RM; Nielsen UB; Kirpotin DB; Poul MA; Marks JD; Benz CC
    Biochem Biophys Res Commun; 2001 Jan; 280(1):274-9. PubMed ID: 11162510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.
    Adams GP; Schier R; McCall AM; Simmons HH; Horak EM; Alpaugh RK; Marks JD; Weiner LM
    Cancer Res; 2001 Jun; 61(12):4750-5. PubMed ID: 11406547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Expression of anti-HBc single-chain variable fragment mediated by recombinant replication defective adenovirus in vitro].
    Tang ZH; Yu YS; Ma HH; Jiang H; Xi M; Zang GQ; Yao JL
    Zhonghua Gan Zang Bing Za Zhi; 2006 Aug; 14(8):587-9. PubMed ID: 16938170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A gutless adenoviral vector expressing full-length anti-Her2 antibody.
    Jiang MH; Chen L; Li LF; Wu HP; Jiang LH; Qian YZ; Fang GE; Xue XC
    Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):e26-31. PubMed ID: 19473346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A strategy for adenovirus vector targeting with a secreted single chain antibody.
    Glasgow JN; Mikheeva G; Krasnykh V; Curiel DT
    PLoS One; 2009 Dec; 4(12):e8355. PubMed ID: 20027223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Considerations and challenges for the achievement of targeted gene delivery.
    Curiel DT
    Gene Ther; 1999 Sep; 6(9):1497-8. PubMed ID: 10490758
    [No Abstract]   [Full Text] [Related]  

  • 56. A phase I study of recombinant adenovirus vector-mediated delivery of an anti-erbB-2 single-chain (sFv) antibody gene for previously treated ovarian and extraovarian cancer patients.
    Alvarez RD; Curiel DT
    Hum Gene Ther; 1997 Jan; 8(2):229-42. PubMed ID: 9017426
    [No Abstract]   [Full Text] [Related]  

  • 57. High in vivo production of a model monoclonal antibody on adenoviral gene transfer.
    Noël D; Pelegrin M; Kramer S; Jacquet C; Skander N; Piechaczyk M
    Hum Gene Ther; 2002 Aug; 13(12):1483-93. PubMed ID: 12215269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phosphorylation sensitivity of the commonly used anti-p185neu/erbB2 monoclonal antibody clone 3B5 suggests selective usage of autophosphorylation sites.
    DiGiovanna MP
    Anal Biochem; 1997 Apr; 247(1):167-70. PubMed ID: 9126388
    [No Abstract]   [Full Text] [Related]  

  • 59. Construction of tumor-specific cells expressing a membrane-anchored single-chain Fv of anti-ErbB-2 antibody.
    Suzuki M; Shinkai M; Honda H; Kamihira M; Iijima S; Kobayashi T
    Biochim Biophys Acta; 2001 Feb; 1525(1-2):191-6. PubMed ID: 11342269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biopanning of single-chain antibodies expressing phages reveals distinct expression patterns of angiogenic and arteriogenic vessels.
    Mazur A; Deylig A; Schaper W; Meinertz T; Ito WD
    Endothelium; 2003; 10(4-5):277-84. PubMed ID: 14660088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.